• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在基层医疗环境中,风险筛查器在识别丙型肝炎病毒方面的效果。

Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting.

机构信息

Department of Health and Policy Management, Boston University School of Public Health, Boston, MA, USA.

出版信息

Am J Public Health. 2012 Nov;102(11):e115-21. doi: 10.2105/AJPH.2012.300659. Epub 2012 Sep 20.

DOI:10.2105/AJPH.2012.300659
PMID:22994166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3477946/
Abstract

OBJECTIVES

We evaluated an intervention designed to identify patients at risk for hepatitis C virus (HCV) through a risk screener used by primary care providers.

METHODS

A clinical reminder sticker prompted physicians at 3 urban clinics to screen patients for 12 risk factors and order HCV testing if any risks were present. Risk factor data were collected from the sticker; demographic and testing data were extracted from electronic medical records. We used the t test, χ(2) test, and rank-sum test to compare patients who had and had not been screened and developed an analytic model to identify the incremental value of each element of the screener.

RESULTS

Among screened patients, 27.8% (n = 902) were identified as having at least 1 risk factor. Of screened patients with risk factors, 55.4% (n = 500) were tested for HCV. Our analysis showed that 7 elements (injection drug use, intranasal drug use, elevated alanine aminotransferase, transfusions before 1992, ≥ 20 lifetime sex partners, maternal HCV, existing liver disease) accounted for all HCV infections identified.

CONCLUSIONS

A brief risk screener with a paper-based clinical reminder was effective in increasing HCV testing in a primary care setting.

摘要

目的

我们评估了一项通过初级保健提供者使用的风险筛查器来识别丙型肝炎病毒(HCV)感染风险患者的干预措施。

方法

临床提醒贴纸提示 3 家城市诊所的医生筛查患者是否存在 12 种风险因素,并在存在任何风险时进行 HCV 检测。从贴纸中收集风险因素数据;从电子病历中提取人口统计学和检测数据。我们使用 t 检验、卡方检验和秩和检验比较已筛查和未筛查患者,并开发分析模型以确定筛查器各要素的增量价值。

结果

在接受筛查的患者中,有 27.8%(n=902)被确定至少存在 1 个风险因素。在有风险因素的筛查患者中,有 55.4%(n=500)接受了 HCV 检测。我们的分析表明,7 个要素(注射吸毒、鼻内吸毒、丙氨酸氨基转移酶升高、1992 年前的输血、≥20 个性伴侣、母婴 HCV、现有肝脏疾病)可以发现所有 HCV 感染。

结论

使用纸质临床提醒的简短风险筛查器在初级保健环境中有效增加了 HCV 检测。

相似文献

1
Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting.在基层医疗环境中,风险筛查器在识别丙型肝炎病毒方面的效果。
Am J Public Health. 2012 Nov;102(11):e115-21. doi: 10.2105/AJPH.2012.300659. Epub 2012 Sep 20.
2
Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk.基于初级保健的干预措施与增加对有风险的丙型肝炎病毒检测有关。
Dig Liver Dis. 2012 Jun;44(6):497-503. doi: 10.1016/j.dld.2011.12.014. Epub 2012 Feb 18.
3
Impact of electronic reminder systems on hepatitis C screening in primary care.电子提醒系统对基层医疗中丙型肝炎筛查的影响。
J Viral Hepat. 2018 Aug;25(8):939-944. doi: 10.1111/jvh.12885. Epub 2018 Mar 30.
4
The disposition of hepatitis C antibody-positive patients in an urban hospital.城市医院丙型肝炎抗体阳性患者的处置。
J Viral Hepat. 2009 Nov;16(11):814-21. doi: 10.1111/j.1365-2893.2009.01137.x.
5
Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.在基层医疗机构中,丙氨酸氨基转移酶(ALT)升高、HBsAg 和抗-HCV 的流行情况,以及指南定义的肝炎风险情况的评估。
J Hepatol. 2015 Jun;62(6):1256-64. doi: 10.1016/j.jhep.2015.01.011. Epub 2015 Jan 21.
6
Examining hepatitis C virus testing practices in primary care clinics.检测初级保健诊所中的丙型肝炎病毒检测实践。
J Viral Hepat. 2012 Feb;19(2):e163-9. doi: 10.1111/j.1365-2893.2011.01539.x. Epub 2011 Nov 17.
7
Improving Hepatitis C Virus Screening Rates in Primary Care: A Targeted Intervention Using the Electronic Health Record.提高基层医疗中丙型肝炎病毒筛查率:利用电子健康记录进行的针对性干预
J Healthc Qual. 2015 Sep-Oct;37(5):319-23. doi: 10.1097/JHQ.0000000000000010.
8
Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.在艾滋病诊所中发现的丙型肝炎病毒急性感染:一种筛查策略、风险因素以及对风险的认知。
AIDS Patient Care STDS. 2011 Oct;25(10):571-7. doi: 10.1089/apc.2011.0106. Epub 2011 Aug 22.
9
Lack of health insurance limits the benefits of hepatitis C virus screening: insights from the National Health and Nutrition Examination Hepatitis C follow-up study.缺乏医疗保险限制了丙型肝炎病毒筛查的益处:来自美国国家健康与营养检查丙型肝炎随访研究的见解。
Am J Gastroenterol. 2015 Aug;110(8):1126-33. doi: 10.1038/ajg.2015.31. Epub 2015 Mar 10.
10
Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.基层医疗对丙型肝炎病毒筛查、诊断及患者与适当治疗衔接的观点
Am J Med. 2017 Feb;130(2):S1-S2. doi: 10.1016/j.amjmed.2017.01.001. Epub 2017 Jan 11.

引用本文的文献

1
The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case-Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary Care.卡姆登和伊斯林顿病毒性肝炎识别工具(CIVHIT):在初级保健中使用临床数据库病例发现工具筛查乙型肝炎、丙型肝炎和艾滋病毒。
J Viral Hepat. 2025 Apr;32(4):e14027. doi: 10.1111/jvh.14027. Epub 2024 Oct 24.
2
Screening at a Federally Qualified Health Center in the Midwest for Hepatitis C Among People Who Inject Drugs, 2019-2020.2019-2020 年,中西部地区一家联邦合格健康中心对注射吸毒者进行丙型肝炎筛查。
Prev Chronic Dis. 2021 Jul 15;18:E69. doi: 10.5888/pcd18.200604.
3
Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil.评估在门诊和急诊部门识别丙型肝炎病毒携带者的策略:对巴西丙型肝炎微消除的贡献。
Braz J Infect Dis. 2021 Mar-Apr;25(2):101546. doi: 10.1016/j.bjid.2021.101546. Epub 2021 Feb 23.
4
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy.意大利南部基层医疗环境中丙型肝炎感染的筛查、治疗衔接与治疗
Life (Basel). 2020 Dec 18;10(12):359. doi: 10.3390/life10120359.
5
Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review.医疗机构为改善美国非本土出生人群的结核病检测和治疗转介而采取的策略:一项系统评价。
PLoS One. 2019 Sep 30;14(9):e0223077. doi: 10.1371/journal.pone.0223077. eCollection 2019.
6
The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.异常肝脏试验与初级保健中丙型肝炎检测的关联。
Am J Med. 2020 Feb;133(2):214-221.e1. doi: 10.1016/j.amjmed.2019.07.016. Epub 2019 Jul 29.
7
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.在注射毒品人群中消除丙型肝炎:在卫生系统框架内采取行动的挑战和建议。
Liver Int. 2019 Jan;39(1):20-30. doi: 10.1111/liv.13949. Epub 2018 Sep 22.
8
Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence population.丙型肝炎病毒感染的流行病学和危险因素在高发人群中。
Epidemiol Infect. 2018 Mar;146(4):508-514. doi: 10.1017/S0950268818000080. Epub 2018 Feb 12.
9
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.一次性丙型肝炎筛查策略在初级保健环境中青少年和年轻成人中的成本效益。
Clin Infect Dis. 2018 Jan 18;66(3):376-384. doi: 10.1093/cid/cix798.
10
Direct-acting antiviral agents for HCV infection affecting people who inject drugs.直接作用抗病毒药物治疗影响注射吸毒人群的 HCV 感染。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):641-651. doi: 10.1038/nrgastro.2017.106. Epub 2017 Aug 23.

本文引用的文献

1
Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk.基于初级保健的干预措施与增加对有风险的丙型肝炎病毒检测有关。
Dig Liver Dis. 2012 Jun;44(6):497-503. doi: 10.1016/j.dld.2011.12.014. Epub 2012 Feb 18.
2
HCV screening practices and prevalence in an MCO, 2000-2007.2000-2007 年在一家管理式医疗组织中 HCV 筛查的实施情况和流行率。
Am J Manag Care. 2011;17(8):548-55.
3
Quality of care in patients with chronic hepatitis C virus infection: a cohort study.慢性丙型肝炎病毒感染患者的护理质量:一项队列研究。
Ann Intern Med. 2010 Aug 17;153(4):231-9. doi: 10.7326/0003-4819-153-4-201008170-00005.
4
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial.Boceprevir,一种 NS3 蛋白酶抑制剂,联合聚乙二醇干扰素 alfa-2b 和利巴韦林治疗初治基因 1 型丙型肝炎感染患者的疗效(SPRINT-1):一项开放标签、随机、多中心 2 期临床试验。
Lancet. 2010 Aug 28;376(9742):705-16. doi: 10.1016/S0140-6736(10)60934-8. Epub 2010 Aug 6.
5
Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.在高风险城市门诊环境中丙型肝炎检测的实践和流行情况。
J Viral Hepat. 2011 Jul;18(7):474-81. doi: 10.1111/j.1365-2893.2010.01327.x. Epub 2010 May 20.
6
Public health impact of antiviral therapy for hepatitis C in the United States.美国丙型肝炎抗病毒治疗对公共卫生的影响。
Hepatology. 2009 Dec;50(6):1750-5. doi: 10.1002/hep.23220.
7
Diagnosis, management, and treatment of hepatitis C: an update.丙型肝炎的诊断、管理与治疗:最新进展
Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759.
8
Validation of a hepatitis C screening tool in primary care.丙型肝炎初级保健筛查工具的验证
Arch Intern Med. 2008 Oct 13;168(18):2009-13. doi: 10.1001/archinte.168.18.2009.
9
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
10
Analysis of a hepatitis C screening programme for US veterans.美国退伍军人丙型肝炎筛查项目分析。
Epidemiol Infect. 2006 Apr;134(2):249-57. doi: 10.1017/S095026880500498X.